[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2001002563A3 - HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS - Google Patents

HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS Download PDF

Info

Publication number
WO2001002563A3
WO2001002563A3 PCT/JP2000/003943 JP0003943W WO0102563A3 WO 2001002563 A3 WO2001002563 A3 WO 2001002563A3 JP 0003943 W JP0003943 W JP 0003943W WO 0102563 A3 WO0102563 A3 WO 0102563A3
Authority
WO
WIPO (PCT)
Prior art keywords
proteins
hydrophobic domains
dnas encoding
dnas
human
Prior art date
Application number
PCT/JP2000/003943
Other languages
French (fr)
Other versions
WO2001002563A2 (en
Inventor
Seishi Kato
Tomoko Kimura
Original Assignee
Sagami Chem Res
Protegene Inc
Seishi Kato
Tomoko Kimura
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sagami Chem Res, Protegene Inc, Seishi Kato, Tomoko Kimura filed Critical Sagami Chem Res
Priority to AU52498/00A priority Critical patent/AU5249800A/en
Priority to EP00937278A priority patent/EP1196561A2/en
Priority to JP2001508335A priority patent/JP2003504021A/en
Publication of WO2001002563A2 publication Critical patent/WO2001002563A2/en
Publication of WO2001002563A3 publication Critical patent/WO2001002563A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention provides human proteins having hydrophobic domains, DNAs encoding these proteins, expression vectors for these DNAs, transformed eukaryotic cells expressing these DNAs and antibodies directed to these proteins.
PCT/JP2000/003943 1999-07-02 2000-06-16 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS WO2001002563A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU52498/00A AU5249800A (en) 1999-07-02 2000-06-16 Human proteins having hydrophobic domains and dnas encoding these proteins
EP00937278A EP1196561A2 (en) 1999-07-02 2000-06-16 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS
JP2001508335A JP2003504021A (en) 1999-07-02 2000-06-16 Human protein having hydrophobic domain and DNA encoding the same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP11/188835 1999-07-02
JP18883599 1999-07-02

Publications (2)

Publication Number Publication Date
WO2001002563A2 WO2001002563A2 (en) 2001-01-11
WO2001002563A3 true WO2001002563A3 (en) 2001-07-05

Family

ID=16230684

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2000/003943 WO2001002563A2 (en) 1999-07-02 2000-06-16 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS

Country Status (4)

Country Link
EP (1) EP1196561A2 (en)
JP (1) JP2003504021A (en)
AU (1) AU5249800A (en)
WO (1) WO2001002563A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1157038A4 (en) * 1999-02-26 2005-01-19 Smithkline Beecham Corp Cloning of a p2y-like 7tm receptor (axor17)
EP1280825A2 (en) * 2000-03-16 2003-02-05 Bayer Aktiengesellschaft Regulation of human g protein-coupled receptor
JP2004517604A (en) * 2000-05-18 2004-06-17 インサイト・ゲノミックス・インコーポレイテッド G protein-coupled receptor
US20030157648A1 (en) * 2000-09-11 2003-08-21 Takeo Moriya Novel g protein-coupled receptor proteins and dnas thereof
US20040072751A1 (en) * 2000-10-05 2004-04-15 Masanori Miwa Novel g protein-coupled receptor protein and dna thereof
AU2002219063A1 (en) * 2000-10-31 2002-05-15 Bayer Aktiengesellschaft Human triacylglycerol lipase
WO2002079450A2 (en) * 2001-03-30 2002-10-10 Pe Corporation (Ny) Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
US7049096B2 (en) 2001-04-11 2006-05-23 Bristol-Meyers Squibb Company Polynucleotides encoding a novel human G-protein coupled receptor splice variant HGPRBMY29sv1
US20030143668A1 (en) * 2001-06-18 2003-07-31 National Institute Of Advanced Industrial Guanosine triphosphate-binding protein coupled receptors
US7524638B1 (en) 2003-06-27 2009-04-28 Osi Pharmaceuticals, Inc. Methods for identification of modulators of OSGPR114 or OSGPR78 activity, and their use in the treatment of disease
WO2005117968A2 (en) 2004-04-14 2005-12-15 Genentech, Inc. Compositions and methods comprising an egfl7 antagonist for modulating vascular development
WO2008010986A2 (en) 2006-07-17 2008-01-24 The Board Of Trustees Of The Leland Stanford Junior University Methods of modulating angiogenesis
CN102875677A (en) 2009-05-08 2013-01-16 霍夫曼-拉罗奇有限公司 Humanized anti-egfl7 antibodies and methods using same

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986001532A1 (en) * 1984-08-21 1986-03-13 Celltech Limited Polypeptide and polypeptide composition
WO1998021328A2 (en) * 1996-11-13 1998-05-22 Sagami Chemical Research Center Human proteins having transmembrane domains and dnas encoding these proteins

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986001532A1 (en) * 1984-08-21 1986-03-13 Celltech Limited Polypeptide and polypeptide composition
WO1998021328A2 (en) * 1996-11-13 1998-05-22 Sagami Chemical Research Center Human proteins having transmembrane domains and dnas encoding these proteins

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
D'ANDREA ET AL: "Molecular Cloning of NKB1. A Natural Killer Cell Receptor for HLA-B Allotypes", JOURNAL OF IMMUNOLOGY,US,THE WILLIAMS AND WILKINS CO. BALTIMORE, vol. 155, no. 5, 1 September 1995 (1995-09-01), pages 2306 - 2310, XP002111500, ISSN: 0022-1767 *
DATABASE EMBL EBI; 1 September 1999 (1999-09-01), BIRREN ET AL.: "Homo sapiens chromosome 8 clone RP11-20I12", XP002151133 *
GILLEN C M ET AL: "Molecular cloning and functional expression of the K-Cl cotransporter from rabbit, rat, and human", JOURNAL OF BIOLOGICAL CHEMISTRY,US,AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, vol. 271, no. 27, 5 July 1996 (1996-07-05), pages 16237 - 16244, XP002119528, ISSN: 0021-9258 *
KYTE J ET AL: "A SIMPLE METHOD FOR DISPLAYING THE HYDROPATHIC CHARACTER OF A PROTEIN", JOURNAL OF MOLECULAR BIOLOGY,GB,LONDON, vol. 157, no. 1, 5 May 1982 (1982-05-05), pages 105 - 132, XP000609503, ISSN: 0022-2836 *

Also Published As

Publication number Publication date
EP1196561A2 (en) 2002-04-17
JP2003504021A (en) 2003-02-04
AU5249800A (en) 2001-01-22
WO2001002563A2 (en) 2001-01-11

Similar Documents

Publication Publication Date Title
WO2001049728A3 (en) HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS
WO2000005367A3 (en) Human proteins having hydrophobic domains and dnas encoding these proteins
WO2001012660A3 (en) HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS
WO2000029448A3 (en) Human proteins having hydrophobic domains and dnas encoding these proteins
AU4189799A (en) Prostate growth-associated membrane proteins
NO20016243D0 (en) Anti-alpha-beta3 recombinant human antibodies, nucleic acids encoding the same, and methods of recycling
WO2001002563A3 (en) HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS
EP1571216A3 (en) Phosphodiesterase 8A
WO2004046365A3 (en) Interferon-alpha polypeptides and conjugates
WO2002059315A3 (en) Human nucleic acids and polypeptides and methods of use thereof
WO2000069884A3 (en) Compositions isolated from skin cells and methods for their use
WO2002036627A3 (en) Interferons, uses and compositions related thereto
MXPA01003868A (en) Apomixis conferred by expression of serk interacting proteins.
WO1999049038A3 (en) Human calcium-binding proteins
HUP0103152A3 (en) Monoclonal antibodies directed against the g3bp protein, and uses
WO2001004297A3 (en) Human proteins having hydrophobic domains and dnas encoding these proteins
WO2001000824A3 (en) HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS
WO1999043802A3 (en) HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS
AU2452301A (en) Protein methylarginine-specific antibodies
ZA99677B (en) Placental protein 13.
WO2001088137A3 (en) Human myd88 adapter-like protein and functional fragments thereof
WO2000000506A3 (en) Human proteins having hydrophobic domains and dnas encoding these proteins
AU3452700A (en) Antibodies to placental protein 13
AU7478098A (en) Methods of treatment using nbs-1, antibodies and proteins thereto, and uses of the antibodies
WO2000019210A3 (en) Determining the mechanism of beta-amyloid peptide generation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 508335

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2000937278

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000937278

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2000937278

Country of ref document: EP